Gilead Sciences Inc (GILD)
92.11
-0.52
(-0.56%)
USD |
NASDAQ |
Nov 14, 16:00
92.12
+0.01
(+0.01%)
After-Hours: 20:00
Gilead Sciences Gross Profit (Annual): 20.62B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.62B |
| December 31, 2022 | 21.62B |
| December 31, 2021 | 20.70B |
| December 31, 2020 | 20.12B |
| December 31, 2019 | 17.77B |
| December 31, 2018 | 17.27B |
| December 31, 2017 | 21.74B |
| December 31, 2016 | 26.13B |
| December 31, 2015 | 28.63B |
| December 31, 2014 | 21.10B |
| December 31, 2013 | 8.343B |
| December 31, 2012 | 7.231B |
| December 31, 2011 | 6.261B |
| December 31, 2010 | 6.080B |
| December 31, 2009 | 5.416B |
| December 31, 2008 | 4.209B |
| December 31, 2007 | 3.461B |
| Date | Value |
|---|---|
| December 31, 2006 | 2.593B |
| December 31, 2005 | 1.768B |
| December 31, 2004 | 1.158B |
| December 31, 2003 | 755.17M |
| December 31, 2002 | 397.07M |
| December 31, 2001 | 190.00M |
| December 31, 2000 | 162.04M |
| December 31, 1999 | 152.10M |
| December 31, 1998 | 140.90M |
| December 31, 1997 | 125.90M |
| December 31, 1996 | 37.00M |
| December 31, 1995 | 5.90M |
| March 31, 1995 | 8.80M |
| March 31, 1994 | 6.90M |
| March 31, 1993 | 5.90M |
| March 31, 1992 | 3.80M |
| March 31, 1991 | 2.10M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
17.77B
Minimum
2019
21.62B
Maximum
2022
20.17B
Average
20.62B
Median
2023
Gross Profit (Annual) Benchmarks
| Eli Lilly and Co | 27.04B |
| Merck & Co Inc | 43.99B |
| Vertex Pharmaceuticals Inc | 8.607B |
| Amgen Inc | 19.74B |
| Pfizer Inc | 33.54B |